Gladstone in the News

The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.

The real culprit behind hardened arteries? Stem cells, says landmark study
June 6, 2012

Gladstone Cardiovascular Disease Research Director Dr. Deepak Srivastava is quoted in this report of a breakthrough finding from UC Berkeley.

 

California Stem-cell Agency Shifts Toward Clinical Work
May 25, 2012

Deepak Srivastava, a cardiovascular researcher at the Gladstone Institute in San Francisco, was awarded a $6.3 million grant from the agency today, one of about twenty investigators to receive funds for translational programs.

Mission Bay casts wide net after Salesforce exit
May 25, 2012

When San Francisco-based Salesforce said in 2010 it was moving into Mission Bay, many in the life sciences community were disappointed that the medical and biotech enclave would be filled by high tech workers.

Mission Bay Impresario Retires
May 25, 2012

Bruce Spaulding, one of the architects of San Francisco’s Mission Bay biotech enclave, is retiring for health reasons from the foundation supporting the Gladstone Institutes.

Reducing Brain Activity Aids Memory After Cognitive Decline
May 14, 2012

A study led by a Johns Hopkins neuroscientist and published in the May 10 issue of the journal Neuronsuggests a potential new therapeutic approach for improving memory and interrupting disease progression in patients with a form of cognitive impairment that often leads to full-blown Alzheimer’s disease.

Super cells: The Gladstone Institutes Gala
May 13, 2012

Rare is the soiree that makes science sizzle. But that was the fact last week during the Gladstone Institutes Gala at the Four Seasons Hotel, where 450 guests were greeted by lab-coat-wearing waiters bearing test tubes filled with cocktails.

Gladstone's Dr. Robert M. Grant advises FDA on drug to prevent HIV infection risk
May 10, 2012

History was made Thursday evening as an FDA panel recommended approval of a drug that could prevent the spread of HIV, the virus that causes AIDS -- a disease that has killed 30 million people around the world.

Development of Nuclear Re-programming Technology for Generating Induced Pluripotent Stem Cells
May 10, 2012

Gladstone Institutes' Senior Investigator Dr. Shinya Yamanaka is profiled for his pioneering work in stem cell technology.

F.D.A. Advisory Panel Backs Preventive Use of H.I.V. Drug
May 10, 2012

SILVER SPRING, Md. — A drug already used to treat H.I.V.infection should also be approved to prevent it, an advisory panel to the Food and Drug Administration said on Thursday. The recommendation is the first time that government advisers have advocated giving antiviral medicine to healthy people who might be exposed through sexual activity to the virus that causes AIDS.

Reducing Brain Activity Improves Memory After Cognitive Decline
May 10, 2012

Research in mouse models of familial AD conducted at the Gladstone Institutes of San Francisco has identified mechanisms of the brain that contribute to abnormal excitatory brain activity, as reported in a paper published in the April 27 issue of the journal Cell.